Both our Alderley Park (UK) and Watertown (USA) sites are operational and continue to serve our clients during this difficult time.
Read Evotec’s latest statement on the current
Learn more about microelectrode array technology (MEA) and the role it plays in early toxicology assessment.
Read our comprehensive 14 page review article.
Read our latest blog to learn more about our recent research poster - originally planned for SOT 2020.
The poster highlights the advantages of using a combined in vitro screening approach for effectively identifying early CNS liability.
Read the latest news from parent company, Evotec:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683